ロード中...
Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial
BACKGROUND: In Japan, transarterial infusion chemotherapy using cisplatin (CDDP-TAI) is frequently used for advanced hepatocellular carcinoma (HCC). Moreover, oral chemotherapy with S-1, an oral fluoropyrimidine derivative, has also elicited promising responses in HCC patients. We determined the rec...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4011764/ https://ncbi.nlm.nih.gov/pubmed/24779747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-301 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|